Full Length Research Paper
References
|
Alempijevic T, Zec S, Milosavljevic T. (2017) Drug-induced liver injury: Do we know everything?. World journal of hepatology 9(10):491-502. doi: 10.4254/wjh.v9.i10.491. PMID: 28443154; PMCID: PMC5387361. |
|
|
Almazroo OA, Miah MK, Venkataramanan R (2017). Drug metabolism in the liver. Clinics in liver disease 21(1):1-20. |
|
|
American Diabetes Association (2014). Diagnosis and classification of diabetes mellitus. Diabetes care 37(Supplement_1):S81-S90. |
|
|
Amin M, Suksomboon N (2014). Pharmacotherapy of type 2 diabetes mellitus: an update on drug-drug interactions. Drug safety 37(11):903-919. |
|
|
Arrey WT, Dimala CA, Atashili J, Mbuagbaw J, Monekosso GL (2016). Hypertension, an emerging problem in rural Cameroon: prevalence, risk factors, and control. International Journal of Hypertension, 2016. |
|
|
Bashir A, Sarwal P, Mehta D (2020). Liver Toxicity. In: StatPearls. Treasure Island (FL). Stat Pearls. Accessed 22 May 2020. |
|
|
Carter B. (2002). The extent of potential antihypertensive drug interactions in a Medicaid population. American Journal of hypertension 15(11):953-957. |
|
|
Dara L, Kaplowitz N (2020). Drug?Induced Liver Injury. In: Arias IM, Alter HJ, Boyer JL, Cohen DE, Shafritz DA, Thorgeirsson SS et al., editors. The Liver. Wiley pp. 701-713. |
|
|
De Boer IH, Bangalore S, Benetos A, Davis AM, Michos ED, Muntner P, Bakris G. (2017). Diabetes and hypertension: a position statement by the American Diabetes Association. Diabetes care 40(9):1273-1284. |
|
|
Delacroix S, Chokka RG, Worthley SG (2014). Hypertension: Pathophysiology and treatment. J Neurol Neurophysiol 5(6):1-8. |
|
|
Jáuregui-Garrido B, Jáuregui-Lobera I (2012). Interacciones entre fármacos antihipertensivos y alimentos. Nutrición Hospitalaria 27(6):1866-1875. |
|
|
Khandeparkar A, Rataboli P (2017). A study of harmful drug-drug interactions due to polypharmacy in hospitalized patients in Goa Medical College. Perspectives in clinical research 8(4):180. |
|
|
Paniagua AC, Amariles P (2018). Hepatotoxicity by Drugs. In: Mahlangu N, editor. Pharmacokinetics and Adverse Effects of Drugs - Mechanisms and Risks Factors. InTech. |
|
|
Robles-Díaz M, Medina-Caliz I, Stephens C, Andrade RJ, Lucena MI (2016). Biomarkers in DILI: one more step forward. Frontiers in pharmacology 7:267. |
|
|
Shaw JE, Sicree RA, Zimmet PZ (2010). Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes research and clinical practice 87(1):4-14. |
|
|
van de Vijver S, Akinyi H, Oti S, Olajide A, Agyemang C, Aboderin I, Kyobutungi C (2014). Status report on hypertension in Africa-Consultative review for the 6th Session of the African Union Conference of Ministers of Health on NCD's. Pan African Medical Journal 16(1). |
|
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
